← 홈

Antibody · 대장·직결장암

181개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 181개
AntibodystaleEli LillyPhase 3

Cetuximab wkly (Cetuximab wkly)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib； (Cetuximab β；Fruquintinib；)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib；anti-PD1 antibody； (Cetuximab β；Fruquintinib；anti-PD1 antibody；)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody (Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab, Irinotecan, Capecitabine (Cetuximab, Irinotecan, Capecitabine)

Rectal Neoplasms; Neoadjuvant Treatment · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan (Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab/Gefitinib combination and/or monotherapy (Cetuximab/Gefitinib combination and/or monotherapy)

Colorectal Cancer; Head and Neck Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 1

Cibisatamab (Cibisatamab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleFudan UniversityPreclinical

DEBIRI Combined With Chemotherapy and Bevacizumab (DEBIRI Combined With Chemotherapy and Bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleKahr Bio Australia Pty LtdPhase 2

atezolizumab (Tecentriq, DSP107 + Atezolizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAmsterdam UMC, location VUmcPhase 2

Dose escalation cetuximab (Dose escalation cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleUniversitaire Ziekenhuizen KU L…Phase 2

Dose escalation of cetuximab (Dose escalation of cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleQilu Hospital of Shandong Unive…Preclinical

Doublet or triplet chemotherapy combined with cetuximab (Doublet or triplet chemotherapy combined with cetuximab)

Colon Cancer · Colon Cancer

#ColonCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Drug: XS-03, Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI (Drug: XS-03, Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI)

Colorectal Cancer; Metastatic Colorectal Cancer With RAS Mutation · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab, Tremelimumab and ,FOLFOX)

Colorectal Cancer Metastatic · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E1 - mFOLFOX and durvalumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E2 - mFOLFOX6, durvalumab and oleclumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleMedImmune LLCPhase 2

durvalumab (Imfinzi, E3 - mFOLFOX6, durvalumab and monalizumab)

Microsatellite-stable Colorectal Cancer · Microsatellite-stable Colorectal Cancer

#Microsatellite-stableColorectalC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED

5 / 10 페이지

← 이전다음 →